Using Technology to Match Young Black Men and Transwomen Who Have Sex With Men or Transwomen to HIV Testing Options

April 24, 2017 updated by: Beryl Koblin, Ph, D., New York Blood Center
Young Black men who have sex with men (MSM) and transwomen in the US are affected by HIV at severely disproportionate rates. A key component of HIV prevention for communities at risk is diagnosing HIV infections through regular HIV testing. A significant proportion of young Black MSM and transwomen have not tested in the prior year. This research study seeks to address low HIV testing rates among young Black MSM and transwomen by testing a brief Internet-based HIV testing intervention optimized for mobile devices. The intervention takes advantage of the variety of HIV testing options now available, including the HIV self testing, couples-based HIV counseling and testing and traditional clinic-based testing and will provide men and transwomen with a tailored recommendation of their optimal HIV testing approach. The investigators are conducting a pilot randomized study among young Black MSM and transwomen followed for 6 months to estimate the intervention's potential efficacy in increasing HIV testing.

Study Overview

Status

Unknown

Conditions

Detailed Description

We are conducting a pilot study among 240 young Black MSM and transgender women randomized to the Intervention Arm (assessment and algorithm to deliver a tailored recommendation) or Control (assessment and standard HIV testing information) and followed for 6 months to estimate the intervention's potential efficacy in increasing HIV testing. After informed consent, participants are asked to provide contact information on the locator form. Then, participants complete a brief quantitative assessment including basic demographics, HIV testing history and other factors related to HIV testing. All participants, regardless of study arm, then receive information about each HIV testing method including how the tests are conducted (blood, oral sample), and availability of counseling and support. Participants then are randomized into 1 of the 2 study arms. A computer program will randomly assign each participant using randomly ordered block sizes of 4 and 6 and stratified by age (16-23, 24-29 years) to balance groups.

Participants assigned to the Intervention Arm will complete a brief quantitative assessment lasting approximately 2-3 minutes to assess those factors associated with HIV testing and thus are needed to complete the algorithm. They then receive the results of the HIV testing algorithm, presented as their personalized HIV testing approach. All participants will receive information on resources in New York City to test by all of these methods. The control participants are provided with the above information about each testing approach but without a recommended approach.

Study Type

Interventional

Enrollment (Actual)

236

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • New York, New York, United States, 10065
        • New York Blood Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 29 years (ADULT, CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • male at birth;
  • self-identify as Black, African American, Caribbean Black, African Black or multiethnic Black;
  • able to read and respond in English;
  • between 16-29 years of age;
  • known to be HIV-infected;
  • insertive or receptive anal intercourse with a man or transwoman in the last 12 months;
  • reside in the New York City metropolitan area

Exclusion Criteria:

  • enrolled in any other HIV research study involving HIV testing
  • participant in an HIV vaccine trial
  • currently taking pre-exposure prophylaxis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: All About Me
assessment and algorithm to provide participants with a tailored recommendation of their optimal HIV testing approach
Assessment and algorithm to determine recommended HIV testing approach
ACTIVE_COMPARATOR: Control
HIV testing information
HIV testing information

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants reporting having an HIV test as assessed by questionnaire
Time Frame: 3 months
Self-reported HIV test in the prior 3 months assessed by questionnaire
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants who are aware of HIV self-testing and couples based voluntary counseling and testing as assessed by questionnaire
Time Frame: 3 months
Self-reported awareness of HIV self-testing and couples based voluntary counseling and testing assessed by questionnaire
3 months
Number of intervention participants recommended a self-test who use a self-test as assessed by questionnaire
Time Frame: 3 months
Self-reported use of self test among those recommended a self test - Intervention participants only
3 months
Number of intervention participants recommended testing at a clinic who test at a clinic as assessed by questionnaire
Time Frame: 3 months
Self-reported use of testing at a clinic among those recommended to test at a clinic - Intervention participants
3 months
Number of intervention participants recommended couples testing who test using couples testing as assessed by questionnaire
Time Frame: 3 months
Self-reported use of couples testing among those recommended to test using couples testing - Intervention only
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Beryl Koblin, PhD, NY Blood Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2016

Primary Completion (ANTICIPATED)

December 1, 2017

Study Completion (ANTICIPATED)

December 1, 2017

Study Registration Dates

First Submitted

May 23, 2016

First Submitted That Met QC Criteria

July 14, 2016

First Posted (ESTIMATE)

July 15, 2016

Study Record Updates

Last Update Posted (ACTUAL)

April 25, 2017

Last Update Submitted That Met QC Criteria

April 24, 2017

Last Verified

April 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 473699-41

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on HIV Testing

Clinical Trials on All About Me

3
Subscribe